Oura buys AI primary care startup Counsel Health for $625M
Oura is acquiring Counsel Health for $625 million to expand AI healthcare services.
Why it matters: This deal signals growing AI innovation in healthcare tech, raising future legal compliance and data privacy questions for health professionals.
- Oura announced the $625 million cash acquisition of Counsel Health on November 10, 2026.
- Counsel Health’s AI-driven service was integrated into the Oura app in June 2026, enabling AI and physician chats.
- Oura postponed its planned $2.2 billion IPO in September 2026 due to market uncertainty.
- Counsel Health has 70 employees joining Oura; its CEO becomes Chief Clinical AI Officer.
- Oura reported $533 million quarterly revenue (Q3 2026), up 153% year-over-year, with annual revenue around $1.75 billion in 2026.
- Oura’s valuation hit $11 billion after a $900 million funding round in October 2025.
On November 10, 2026, Oura announced its $625 million acquisition of Counsel Health, an AI-native primary care startup. Counsel Health powers a chat-based medical experience that connects users with licensed physicians, blending AI and clinical care.
The acquisition follows Oura’s postponement of its up to $2.2 billion IPO, which was paused in late September due to IPO market uncertainties.
Since June 2026, Counsel Health’s service has been integrated into the Oura app, allowing users to interact with medical AI for personalized advice and have chats with physicians directly within the app.
Oura CEO Tom Hale said the move helps members take comprehensive action on their health — from quick questions to prescriptions, lab tests, chronic care, and referrals. Counsel Health CEO Muthu Alagappan emphasized their focus on medical AI built around "trust, safety and responsibility," maintaining physicians as key clinical decision-makers.
The Counsel Health team of 70 employees will join Oura, with Alagappan stepping into the newly created role of Chief Clinical AI Officer.
Oura’s financials show strong momentum: quarterly revenue hit $533 million by September 30, 2026, climbing 153% year-over-year, and its fiscal 2026 revenue reached roughly $1.75 billion, up 92% from the prior year. The company was valued at $11 billion after a late-stage $900 million funding round in October 2025.
This acquisition advances Oura’s strategy to become a holistic health platform, blending biometric tracking with AI-powered primary care. It also highlights ongoing healthcare tech innovation, raising potential legal compliance and health data privacy questions as AI plays a larger role in patient care.
By the numbers:
- $625 million — acquisition price for Counsel Health
- 153% — Oura's year-over-year revenue growth for Q3 2026
- 70 — Counsel Health employees joining Oura
Yes, but: The deal’s integration and regulatory approval details remain unclear, as does its impact on Oura’s IPO timeline.
What's next: Expect further developments on how Counsel Health’s services will be fully integrated and any regulatory filings or approvals required.